Zentek Ltd. (NASDAQ:ZTEK – Get Rating) was the recipient of a large decline in short interest in August. As of August 31st, there was short interest totalling 1,300 shares, a decline of 98.0% from the August 15th total of 63,800 shares. Based on an average daily trading volume, of 23,600 shares, the short-interest ratio is currently 0.1 days.
Zentek Trading Up 3.1 %
Shares of ZTEK stock traded up $0.06 during mid-day trading on Tuesday, reaching $2.01. 2,665 shares of the company's stock traded hands, compared to its average volume of 19,635. Zentek has a 12 month low of $1.51 and a 12 month high of $5.95. The firm's 50-day simple moving average is $2.09.
Get Zentek alerts:Zentek (NASDAQ:ZTEK – Get Rating) last announced its earnings results on Wednesday, June 29th. The company reported ($0.04) EPS for the quarter. Zentek had a negative net margin of 1,617.24% and a negative return on equity of 405.71%. The business had revenue of $0.13 million for the quarter.
Hedge Funds Weigh In On Zentek
Several large investors have recently modified their holdings of ZTEK. JPMorgan Chase & Co. purchased a new position in shares of Zentek in the 1st quarter worth about $25,000. Cutter & CO Brokerage Inc. purchased a new position in shares of Zentek in the 2nd quarter worth about $27,000. Cambridge Investment Research Advisors Inc. purchased a new position in shares of Zentek in the 1st quarter worth about $32,000. National Bank of Canada FI purchased a new position in shares of Zentek in the 1st quarter worth about $63,000. Finally, Bank of Montreal Can purchased a new position in shares of Zentek in the 1st quarter worth about $199,000. Hedge funds and other institutional investors own 0.79% of the company's stock.Analyst Upgrades and Downgrades
Separately, Lake Street Capital assumed coverage on shares of Zentek in a report on Thursday, June 30th. They set a "buy" rating and a $3.50 target price on the stock.
Zentek Company Profile
(Get Rating)
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound.
Read More
- Get a free copy of the StockNews.com research report on Zentek (ZTEK)
- This Is What To Expect From The S&P 500 Now
- The Two Things You Need To Know About Oracle's FQ1 Report
- Three Value Stocks For A Volatile Market
- 3 Energy Stocks Nearing Breakouts From Cup-Shaped Patterns
- Do These Dividend Achievers Deserve A Place In Your Portfolio?
Receive News & Ratings for Zentek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentek and related companies with MarketBeat.com's FREE daily email newsletter.